Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1743121 Target Snapshot

Solute carrier organic anion transporter family member 1B3 · SINGLE PROTEIN · Homo sapiens

2,121Compounds
130Assays
62Approved Drugs
205.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9NPD5. Use UniProt Q9NPD5 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9NPD5 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Solute carrier organic anion transporter family member 1B3 as ChEMBL target CHEMBL1743121, mapped to UniProt Q9NPD5. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Solute carrier organic anion transporter family member 1B3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1743121
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9NPD5
Solute carrier organic anion transporter family member 1B3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Solute carrier organic anion transporter family member 1B3 is the right protein anchor across sources, using UniProt Q9NPD5 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSolute carrier organic anion transporter family member 1B3
UniProt AccessionQ9NPD5
Component TypeProtein
Sequence Length702 aa

Solute carrier organic anion transporter family member 1B3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Solute carrier organic anion transporter family member 1B3, mapped to UniProt Q9NPD5. Sequence length is 702 aa.

Mapped IDQ9NPD5
Review nameSolute carrier organic anion transporter family member 1B3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

62
Approved
9
Phase III
8
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC50109.0
KI93.0
EC503.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4636474 8.85 EC50 1.4 Preclinical
CHEMBL4637446 8.62 EC50 2.4 Preclinical
CHEMBL4633668 8.52 EC50 3.0 Preclinical
CHEMBL1171146 7.1 Ki 80.0 Preclinical
CHEMBL1171146 6.98 IC50 104.71 Preclinical
CHEMBL160 6.89 IC50 130.0 Approved
CHEMBL3704745 6.72 IC50 190.0 Preclinical
CHEMBL1651956 6.66 IC50 220.0 Clinical
CHEMBL428647 6.58 IC50 260.0 Approved
CHEMBL1163 6.43 Ki 370.0 Approved
Distribution

pChEMBL Value Distribution

61
5.0
67
5.5
28
6.0
5
6.5
1
7.0
0
7.5
0
8.0
3
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ATAZANAVIR
CHEMBL1163
Approved 2003
OLMESARTAN MEDOXOMIL
CHEMBL1200692
Approved 2002
TELMISARTAN
CHEMBL1017
Approved 1998
LOSARTAN
CHEMBL191
Approved 1995
PACLITAXEL
CHEMBL428647
Approved 1992
MOMETASONE FUROATE
CHEMBL1161
Approved 1987
CYCLOSPORINE
CHEMBL160
Approved 1983
HYDROXYZINE PAMOATE
CHEMBL1200467
Approved 1959
Assay Landscape

Assay Landscape

130
Total Assays
107
Tested Compounds
3
Assay Types
ADME — 79 assays, 107 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 61 96 5.6
single protein format 14 11 5.1
assay format 4 0
Functional — 27 assays, 3 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 27 3 5.2
Binding — 24 assays, 7 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 14 2 4.8
cell-based format 10 5 6.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine